OraSure Technologies (OSUR) Stock Forecast: StockMap's 2-Week Call

OSUR stock forecast: StockMap's model makes no two-week call on OraSure Technologies after the Nov 13 close: its evidence is split, 2 reasons for and 13 against. Too few two-week windows graded to judge yet.

OraSure Technologies last closed at $3.62, +0.00% on the session.

Against the IVW growth benchmark the position is +0.91% over the forecast window.

OraSure Technologies' market cap is $249.95M as of November 13, 2026.

No call today: the model sees no clear direction · the next 2 weeks, vs S&P 500 growth. The lean on a scale from −100 to +100 is -10 (too close to call).

Where OSUR sits: sized by market cap, coloured by the day's move.

The read is built from 15 underlying insights — 2 bullish and 13 bearish.

Agreement across those insights is 87%.

9 daily calls for OSUR so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks OraSure Technologies in the 29th percentile on return on equity, where 100 is best.

OraSure Technologies is classified under Health Care / Health Care Equipment & Supplies.

StockMap tracks OraSure Technologies as the 91st largest of the 142 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.

Across that group the current two-week reads are 74 Neutral, 52 Moderate Underperform, 13 Strong Underperform and 3 Moderate Outperform.

On that composite OraSure Technologies ranks 62nd of 142 in the group, against a group median of -0.15.

Other Health Care stocks

Research and education, not investment advice. The calls on this page come from StockMap's automated model, run on the close of November 13, 2026, and are the same for every reader. Calls are graded in public, misses included: how calls are graded, and the record. Who makes the calls and who pays for the site: Disclosures.

OraSure Technologies (OSUR) — StockMap 2-week forecast & tracked accuracy